Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases.
Sadeghian
G
G
Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran. Sadeghian@sdlrc.mui.ac.ir
Ziaei
H
H
Shirani-Bidabadi
L
L
Nilforoushzadeh
M A
MA
D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002908:Chronic Disease; D002921:Cicatrix / Q000469:parasitology*; D003937:Diagnosis, Differential; D006801:Humans; D007492:Iran / Q000453:epidemiology; D018320:Leishmania major; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology; D008177:Lupus Vulgaris / Q000175:diagnosis; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D012008:Recurrence; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate